NSTEMI/ACS Risk Stratification (ESC 2023)
NSTEMI/ACS Risk Stratification (ESC 2023): NSTE-ACS Confirmed → Very High Risk Features? → Immediate ICA (<2h) → Antithrombotic Therapy → PCI/CABG as In...
Interactive Decision Tree
Algorithm Steps
- ▶Start
NSTE-ACS Confirmed
Troponin positive, no ST elevation
- Dynamic troponin rise/fall pattern
- Ischemic symptoms
- ECG: ST depression, T-wave changes, or normal
- ◆Decision
Very High Risk Features?
Assess for immediate ICA criteria
- Hemodynamic instability / cardiogenic shock
- Recurrent/refractory chest pain
- Life-threatening arrhythmias
- Mechanical complications
- Acute heart failure with ongoing ischemia
- Recurrent dynamic ST/T changes
If Yes:
- ●Action
Immediate ICA (<2h)
Very high risk - emergent angiography
- Activate cath lab
- Treat as STEMI-equivalent urgency
- Hemodynamic support if needed
- ●Action
Antithrombotic Therapy
All NSTE-ACS patients
- Aspirin loading 150-300mg
- P2Y12 inhibitor (timing per strategy)
- Anticoagulation: UFH or LMWH or Fondaparinux
- Fondaparinux preferred if conservative
- ✓Outcome
PCI/CABG as Indicated
Based on angiographic findings
- ✓Outcome
Optimal Medical Therapy
If no significant CAD or not revascularizable
If No:
- ◆Decision
High Risk Features?
Assess for early invasive strategy
- Confirmed NSTEMI (troponin rise/fall)
- GRACE score >140
- Dynamic ST/T-wave changes
- Transient ST-elevation
If Yes:
- ●Action
Early Invasive (<24h)
Class IIa recommendation (2023 downgrade)
- ICA within 24 hours
- Note: Downgraded from Class I in 2020
- Based on TIMACS, VERDICT trials
If No:
- ●Action
Non-High Risk
Selective invasive or non-invasive strategy
- No high-risk features
- Low GRACE score
- Stable, no dynamic changes
- ●Action
Non-Invasive Testing
Stress testing or CT coronary angiography
- Stress echo or stress CMR
- CTCA for low-intermediate PTP
- ICA if positive stress test
- ●Action
Calculate GRACE Score
Risk stratification tool
- Age, Heart rate, Systolic BP
- Creatinine, Killip class
- Cardiac arrest at admission
- ST deviation, Elevated markers
- >140 = High risk, <140 = Lower risk
Guideline Source
2023 ESC Guidelines for the Management of Acute Coronary Syndromes
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- GRACE score calculator not integrated - use separate tool
- Does not address specific antithrombotic dosing
- Assumes confirmed NSTEMI diagnosis
- Complex patients require cardiology consultation
Contraindicated Populations
Applicable Regions
EU: ESC 2023 - ICA <24h now Class IIa (downgraded from Class I)
US: ACC/AHA similar approach with clinician judgment
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the NSTEMI/ACS Risk Stratification (ESC 2023)?
The NSTEMI/ACS Risk Stratification (ESC 2023) is a risk assessment clinical algorithm for Cardiology. It provides a structured decision tree to guide clinical decision-making, based on 2023 ESC Guidelines for the Management of Acute Coronary Syndromes.
What guideline is the NSTEMI/ACS Risk Stratification (ESC 2023) based on?
This algorithm is based on 2023 ESC Guidelines for the Management of Acute Coronary Syndromes (DOI: 10.1093/eurheartj/ehad191).
What are the limitations of the NSTEMI/ACS Risk Stratification (ESC 2023)?
Known limitations include: GRACE score calculator not integrated - use separate tool; Does not address specific antithrombotic dosing; Assumes confirmed NSTEMI diagnosis; Complex patients require cardiology consultation. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the NSTEMI/ACS Risk Stratification (ESC 2023) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free